Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer.
about
Gene therapy for carcinoma of the breast: Pro-apoptotic gene therapyThe mammary myoepithelial cell--Cinderella or ugly sister?CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian originTranscriptomic changes in human breast cancer progression as determined by serial analysis of gene expressionProgress in the application of DNA microarraysEvaluation of the similarity of gene expression data estimated with SAGE and Affymetrix GeneChipsGene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinomaCirculating and disseminated tumor cells: diagnostic tools and therapeutic targets in motionGenomic-Wide Analysis with Microarrays in Human OncologyThe ATDC (TRIM29) protein binds p53 and antagonizes p53-mediated functionsProteomic profiling of human keratinocytes undergoing UVB-induced alternative differentiation reveals TRIpartite Motif Protein 29 as a survival factorKallikrein gene downregulation in breast cancer.Discovery of novel tumor markers of pancreatic cancer using global gene expression technology.Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer.Comparison of hybridization-based and sequencing-based gene expression technologies on biological replicates.Building pathway clusters from Random Forests classification using class votesTranscriptomic signature of bexarotene (rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models.Transcriptomic and proteomic profiling of two porcine tissues using high-throughput technologies.Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells.Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancerAn epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urineInduction of antitumor immunity by dendritic cells loaded with membrane-translocating mucin 1 Peptide antigen.Ataxia-telangiectasia group D complementing gene (ATDC) promotes lung cancer cell proliferation by activating NF-κB pathwayA D-peptide analog of the second extracellular loop of claudin-3 and -4 leads to mislocalized claudin and cellular apoptosis in mammary epithelial cells.Dephosphorylation and biodistribution of 1-¹³C-phospholactate in vivo.Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells.TRIM29 suppresses TWIST1 and invasive breast cancer behavior.Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4.Tissue specific DNA methylation in normal human breast epithelium and in breast cancerImmunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkersTransmembrane mucins as novel therapeutic targetsHigh frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer.Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissuesIn silico gene expression analysis--an overview.The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancerInterleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer.Targeted imaging of breast tumor progression and therapeutic response in a human uMUC-1 expressing transgenic mouse model.Expression of underglycosylated MUC1 antigen in cancerous and adjacent normal breast tissues.Combined Treatment with Epigenetic, Differentiating, and Chemotherapeutic Agents Cooperatively Targets Tumor-Initiating Cells in Triple-Negative Breast Cancer.Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway
P2860
Q24797919-A84B200B-2914-4812-B652-87087D28FB7DQ24801073-2E2879A7-245F-48F9-B3FD-7791C9142B13Q24804759-FAB84297-2784-4F43-835A-DDB59530E518Q24806240-B18C2029-BCE4-4FE3-84CD-54C4D8447AA9Q24813217-3D24D3ED-3EAB-464E-B2B3-599E907D6BF3Q24813318-C660C82F-C4B6-48E8-9668-9534D6564BB8Q27490242-14DF0053-034F-4514-9825-84F5B71A154FQ28066285-EF3A4132-F3F9-423C-BAD8-A44C846F558CQ28081059-D5C7FB55-D118-449A-8332-E0B40DC12BD0Q28593750-96EA98DA-8F4D-4728-97A7-03436DF8CD93Q28752381-517B43BB-1C79-4FBB-A4E9-7825B98FC636Q30438640-503B3CDE-2B77-4449-BA29-1309B1B2FFE9Q31048088-8F2C2F0C-ADD3-4C98-8B93-E6B82D7201D6Q33239655-D9772F74-710B-41D1-93B6-BE780F5A0681Q33287052-92C475D5-137F-4511-AABD-151A6B224908Q33318578-B889DED5-2AFE-4112-BEFB-19EAE6917147Q33368864-80AB62E7-C721-488F-B934-DD0BEC244AC8Q33400860-3CAE19F2-A8E9-40D2-AF49-450E7038EA35Q33966952-FDF04767-10DB-4425-93F7-1FC2FDD4BDD3Q34103462-A0E5A99A-66C3-440A-9A12-9991FCDB3924Q34221765-FA3E195F-61D2-403D-B684-C85EB5202E06Q34518328-7BA49735-C112-4B94-B9AC-7E8808574BF1Q34775578-D846FDCA-8531-4A9F-8EE5-904D6512204EQ34823180-F558C319-298C-4151-AAEF-96782A6EE455Q34872817-CED1BC3F-E90C-40BB-874C-956E4864294DQ34928974-4A198D77-A876-48D3-8EF7-0BB9A5763529Q35087555-6E5C516C-6A96-47C6-B560-0F6DE5A82071Q35098046-84EB0BF0-DDE4-46C1-AD5D-03ABE7AC749CQ35126044-46849A22-D186-4B88-931B-826830411B4AQ35151124-1F4FA4A8-89EB-467E-960E-9AB522153933Q35632645-CFCF04C4-889C-4B70-916E-4E82D73B7BEDQ35759154-612A1A43-B944-4182-9AEA-761635B89851Q35789355-601FFA2B-C913-47BF-AC43-7F889C192790Q35971444-520B064C-75B8-44F3-A85B-B769D1B5FC1BQ35996059-8D932844-65C2-411F-8CC4-0FFEA0081CC9Q36557683-7AEFBA30-E343-4C01-993E-89A7AF7CE0CFQ36612156-DD8375BC-DB81-4D83-87C5-459A43C7711FQ36625687-C8824441-D035-4BCE-B6C3-73519CC8CD47Q36918202-67CAE20C-5D7D-46C4-B204-F3DC646328D1Q37046419-E86C4015-50CA-4A09-AFA3-DB72C2357087
P2860
Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Combining serial analysis of g ...... ly expressed in breast cancer.
@ast
Combining serial analysis of g ...... ly expressed in breast cancer.
@en
type
label
Combining serial analysis of g ...... ly expressed in breast cancer.
@ast
Combining serial analysis of g ...... ly expressed in breast cancer.
@en
prefLabel
Combining serial analysis of g ...... ly expressed in breast cancer.
@ast
Combining serial analysis of g ...... ly expressed in breast cancer.
@en
P2093
P1433
P1476
Combining serial analysis of g ...... ly expressed in breast cancer.
@en
P2093
Ferguson AT
Petroziello JM
P304
P407
P577
1999-11-01T00:00:00Z